A Study to Evaluate the Safety and Immunogenicity of RSVpreF Coadministered With Herpes Zoster Vaccine in Adults

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This purpose of this phase 3 multicenter, parallel-group, open-label study is to learn about the safety, tolerability, and immunogenicity of RSVpreF and HZ/su vaccine when given together in adults 50 years of age and older.
Epistemonikos ID: 762b63abaaf9d03998e69f317a74d6501bd594ec
First added on: Mar 26, 2025